Tag: Pharmas
Synopsis: Sun Pharma is in focus on a potential $12 billion Organon deal and biosimilars push, seen as a key growth driver supporting global expansion, diversification, and earnings upside. The…
Between 2025 and 2030, the pharmaceutical industry faces its most dramatic patent cliff in history, with up to $300 billion in branded drug revenues exposed to generic competition. The upheaval…